The Medscape team is back in Chicago for the much-anticipated ACC 2025 conference,  March 29-31, bringing an array of ...

Johnson & Johnson (J&J) has announced that it will be investing more than $55bn into the US over the next four years. The ...

With the advent of tools like Hotjar and UserPilot, both incorporating AI into their customer data offerings, it is now ...

Alnylam Pharmaceuticals’ Amvuttra (vutrisiran) has been approved by the Food and Drug Administration (FDA) to treat ...

AstraZeneca (AZ) has said it will be investing $2.5bn in China over the next five years to “further advance life sciences” in ...

It is becoming an essential factor not only in the successful integration of medicines into clinical practice but also in ...

Pharma companies must balance HCP access and MHRA/ABPI compliance by preventing public search indexing of promotional ...

Almirall has announced that it will be hosting the 16th edition of its Skin Academy, a conference that encourages ...

AbbVie’s Elahere (mirvetuximab soravtansine-gynx) has demonstrated consistent survival benefits in a subset of ovarian cancer ...

As we approach 2025, healthcare and life sciences SMEs face an increasingly digital world. A seamless, mobile-friendly ...

ABPI's recent update permits QR codes in printed pharmaceutical materials for prescribing information. By ensuring visibility ...

Sanofi has announced that it will be broadening its immunology pipeline by acquiring Dren Bio’s phase 1 CD20-directed ...